SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-092402
Filing Date
2019-03-29
Accepted
2019-03-29 14:04:12
Documents
52
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 10-Q d665348d10q.htm 10-Q 456852
2 EX-31.1 d665348dex311.htm EX-31.1 10539
3 EX-31.2 d665348dex312.htm EX-31.2 10691
4 EX-32 d665348dex32.htm EX-32 5346
  Complete submission text file 0001193125-19-092402.txt   8707844

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT neog-20190228.xml EX-101.INS 3376183
6 XBRL TAXONOMY EXTENSION SCHEMA neog-20190228.xsd EX-101.SCH 29379
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20190228_cal.xml EX-101.CAL 34137
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20190228_def.xml EX-101.DEF 246783
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20190228_lab.xml EX-101.LAB 289603
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20190228_pre.xml EX-101.PRE 271842
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 19715525
SIC: 2835 In Vitro & In Vivo Diagnostic Substances